PCED1B report

Query

Invalid input gene. Please select from the suggestions.

I. Expression across cell types

Cell ontologyData table

Name	Number of supported studies	Average coverage
regulatory T cell	16 studies	27% ± 8%	Explore
endothelial cell	12 studies	33% ± 11%	Explore
CD4-positive, alpha-beta T cell	12 studies	25% ± 9%	Explore
CD8-positive, alpha-beta T cell	12 studies	23% ± 10%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	11 studies	30% ± 9%	Explore
T cell	10 studies	32% ± 13%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	10 studies	30% ± 8%	Explore
microglial cell	8 studies	30% ± 10%	Explore
adipocyte	8 studies	43% ± 11%	Explore
natural killer cell	7 studies	26% ± 10%	Explore
mucosal invariant T cell	6 studies	25% ± 10%	Explore
macrophage	6 studies	24% ± 7%	Explore
CD4-positive, alpha-beta memory T cell	5 studies	19% ± 3%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	30% ± 11%	Explore
mast cell	5 studies	25% ± 10%	Explore
B cell	5 studies	27% ± 6%	Explore
type I pneumocyte	5 studies	24% ± 4%	Explore
fibroblast	5 studies	26% ± 12%	Explore
smooth muscle cell	5 studies	28% ± 9%	Explore
CD16-negative, CD56-bright natural killer cell, human	4 studies	24% ± 6%	Explore
dendritic cell	4 studies	18% ± 2%	Explore
astrocyte	4 studies	38% ± 15%	Explore
CD8-positive, alpha-beta memory T cell	4 studies	24% ± 5%	Explore
CD16-positive, CD56-dim natural killer cell, human	3 studies	24% ± 9%	Explore
vein endothelial cell	3 studies	25% ± 13%	Explore
effector CD4-positive, alpha-beta T cell	3 studies	20% ± 2%	Explore
exhausted T cell	3 studies	28% ± 6%	Explore
endothelial cell of vascular tree	3 studies	18% ± 1%	Explore
glutamatergic neuron	3 studies	40% ± 2%	Explore
effector memory CD4-positive, alpha-beta T cell	3 studies	22% ± 2%	Explore
alveolar macrophage	3 studies	51% ± 11%	Explore
ciliated cell	3 studies	24% ± 7%	Explore
lymphocyte	3 studies	49% ± 11%	Explore
basal cell	3 studies	34% ± 20%	Explore
plasmacytoid dendritic cell	3 studies	21% ± 6%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	3 studies	27% ± 13%	Explore
T follicular helper cell	3 studies	25% ± 6%	Explore
mature NK T cell	3 studies	20% ± 5%	Explore

II. Expression across tissues

sc-RNAseq dataData table

Name	Number of supported studies	Average coverage
lung	4 studies	20% ± 2%	Explore
peripheral blood	3 studies	16% ± 1%	Explore
brain	3 studies	28% ± 4%	Explore

Bulk RNAseq dataData table

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
breast	100%	574.26	458 / 459	96%	21.38	1074 / 1118
lung	100%	846.90	578 / 578	96%	17.41	1107 / 1155
bladder	100%	891.81	21 / 21	95%	17.57	479 / 504
intestine	99%	819.28	960 / 966	92%	11.04	483 / 527
uterus	100%	702.96	170 / 170	87%	10.52	398 / 459
ovary	100%	1618.39	180 / 180	84%	8.54	363 / 430
thymus	91%	332.57	597 / 653	92%	13.31	559 / 605
kidney	100%	472.62	89 / 89	84%	9.27	755 / 901
adrenal gland	100%	2695.86	258 / 258	80%	17.56	183 / 230
esophagus	84%	232.19	1210 / 1445	89%	9.94	162 / 183
prostate	99%	565.82	243 / 245	61%	3.87	304 / 502
stomach	66%	174.97	237 / 359	93%	11.73	265 / 286
pancreas	45%	93.43	147 / 328	97%	20.42	172 / 178
skin	66%	165.27	1185 / 1809	68%	10.35	323 / 472
liver	74%	152.98	167 / 226	59%	5.28	240 / 406
brain	54%	117.59	1419 / 2642	66%	5.38	466 / 705
lymph node	0%	0	0 / 0	100%	97.68	29 / 29
spleen	100%	2610.12	241 / 241	0%	0	0 / 0
ureter	0%	0	0 / 0	100%	20.96	1 / 1
blood vessel	100%	988.62	1334 / 1335	0%	0	0 / 0
adipose	99%	589.38	1196 / 1204	0%	0	0 / 0
tonsil	0%	0	0 / 0	98%	13.52	44 / 45
peripheral blood	97%	1064.66	904 / 929	0%	0	0 / 0
heart	52%	125.34	445 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	18%	1.47	14 / 80
muscle	3%	5.81	25 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0